Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10281 | 1011 | 33.3 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
361 | 16717 | ACINETOBACTER BAUMANNII//ESBL//EXTENDED SPECTRUM BETA LACTAMASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COLISTIN | Author keyword | 207 | 55% | 25% | 256 |
2 | POLYMYXINS | Author keyword | 44 | 63% | 4% | 44 |
3 | COLISTIMETHATE SODIUM | Author keyword | 29 | 88% | 1% | 14 |
4 | IL ANTIINFECT DRUG DEV INNOVAT DRUG DELIVERY | Address | 27 | 92% | 1% | 11 |
5 | POLYMYXIN | Author keyword | 27 | 44% | 5% | 47 |
6 | IL ANTIINFECT DRUG DEV INNOVAT | Address | 18 | 59% | 2% | 20 |
7 | COLISTIN METHANESULFONATE | Author keyword | 18 | 89% | 1% | 8 |
8 | COLISTIMETHATE | Author keyword | 15 | 71% | 1% | 12 |
9 | POLYMYXIN B | Author keyword | 13 | 20% | 6% | 60 |
10 | IL ANTI INFECT DRUG DEV INNOVAT | Address | 11 | 100% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COLISTIN | 207 | 55% | 25% | 256 | Search COLISTIN | Search COLISTIN |
2 | POLYMYXINS | 44 | 63% | 4% | 44 | Search POLYMYXINS | Search POLYMYXINS |
3 | COLISTIMETHATE SODIUM | 29 | 88% | 1% | 14 | Search COLISTIMETHATE+SODIUM | Search COLISTIMETHATE+SODIUM |
4 | POLYMYXIN | 27 | 44% | 5% | 47 | Search POLYMYXIN | Search POLYMYXIN |
5 | COLISTIN METHANESULFONATE | 18 | 89% | 1% | 8 | Search COLISTIN+METHANESULFONATE | Search COLISTIN+METHANESULFONATE |
6 | COLISTIMETHATE | 15 | 71% | 1% | 12 | Search COLISTIMETHATE | Search COLISTIMETHATE |
7 | POLYMYXIN B | 13 | 20% | 6% | 60 | Search POLYMYXIN+B | Search POLYMYXIN+B |
8 | POLYMYXIN E | 10 | 54% | 1% | 13 | Search POLYMYXIN+E | Search POLYMYXIN+E |
9 | COLISTIN SULFATE | 6 | 48% | 1% | 10 | Search COLISTIN+SULFATE | Search COLISTIN+SULFATE |
10 | COLISTIN RESISTANCE | 5 | 37% | 1% | 10 | Search COLISTIN+RESISTANCE | Search COLISTIN+RESISTANCE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTRAVENOUS COLISTIN | 229 | 75% | 16% | 166 |
2 | NEGATIVE BACTERIAL INFECTIONS | 96 | 77% | 7% | 66 |
3 | POLYMYXINS | 54 | 75% | 4% | 39 |
4 | AEROSOLIZED COLISTIN | 53 | 85% | 3% | 28 |
5 | INHALED COLISTIN | 47 | 86% | 2% | 24 |
6 | COLISTIMETHATE | 41 | 100% | 1% | 15 |
7 | COLISTIMETHATE SODIUM | 38 | 89% | 2% | 17 |
8 | COLISTIN METHANESULFONATE | 31 | 61% | 3% | 33 |
9 | COLISTIN | 30 | 26% | 10% | 99 |
10 | POLYMYXIN B | 27 | 18% | 14% | 139 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Susceptibility Testing of the Polymyxins: Where Are We Now? | 2015 | 2 | 11 | 100% |
Adverse Reactions Associated with Systemic Polymyxin Therapy | 2015 | 2 | 31 | 94% |
In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis | 2015 | 2 | 64 | 69% |
Polymyxins revisited | 2008 | 157 | 107 | 73% |
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies | 2012 | 82 | 63 | 54% |
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections | 2006 | 333 | 84 | 67% |
Colistin: new lessons on an old antibiotic | 2012 | 47 | 113 | 80% |
Colistin pharmacokinetics: the fog is lifting | 2012 | 33 | 17 | 100% |
To B or Not to B, That Is the Question: Is It Time to Replace Colistin With Polymyxin B? | 2015 | 1 | 25 | 88% |
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies | 2006 | 203 | 30 | 90% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IL ANTIINFECT DRUG DEV INNOVAT DRUG DELIVERY | 27 | 92% | 1.1% | 11 |
2 | IL ANTIINFECT DRUG DEV INNOVAT | 18 | 59% | 2.0% | 20 |
3 | IL ANTI INFECT DRUG DEV INNOVAT | 11 | 100% | 0.6% | 6 |
4 | ADV THER IES GRP | 2 | 67% | 0.2% | 2 |
5 | UNIDAD CLIN CUIDADOS CRIT | 2 | 67% | 0.2% | 2 |
6 | FARMACEUT CHEM ANALYSE GENEESMIDDELEN | 1 | 31% | 0.4% | 4 |
7 | ANTIMICROBIAL GRP IMMUNOL INFECT DIS | 1 | 50% | 0.2% | 2 |
8 | ICU B | 1 | 100% | 0.2% | 2 |
9 | INTENS CARE UNIT B | 1 | 50% | 0.2% | 2 |
10 | ANTIMICROBIAL PHARMACODYNAM | 1 | 23% | 0.5% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000226687 | ACINETOBACTER BAUMANNII//ACINETOBACTER//A BAUMANNII |
2 | 0.0000145758 | CARBAPENEMASE//OXA 48//KPC |
3 | 0.0000140842 | LPXC//LPXC INHIBITORS//LPXA |
4 | 0.0000135590 | TIGECYCLINE//GLYCYLCYCLINE//GLYCYLCYCLINES |
5 | 0.0000129432 | CHEM BIOCHEM DISCIPLINE//LIPOPOLYAMINES//IND CHEM ENVIROMENTAL ENGN |
6 | 0.0000104986 | METALLO BETA LACTAMASE//METALLO BETA LACTAMASES//VIM 2 |
7 | 0.0000096754 | BACITRACIN//BIOPROC DEV GRP//STABIL TESTING |
8 | 0.0000070324 | FOSFOMYCIN RESISTANCE//FOSFOMYCIN//AREA PROD PORCINA |
9 | 0.0000065516 | CEFTAROLINE//CEFTOBIPROLE//CEFTOLOZANE TAZOBACTAM |
10 | 0.0000065446 | STENOTROPHOMONAS MALTOPHILIA//S MALTOPHILIA//XANTHOMONAS MALTOPHILIA |